Identification of severe acute respiratory syndrome in Canada. - Wikidata - wikimedia - TriplyDB

Identification of severe acute respiratory syndrome in Canada.

Identification of severe acute respiratory syndrome in Canada.

http://www.wikidata.org/entity/Q40562241

about

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro SARS: systematic review of treatment effects Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS)ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN Superspreading SARS events, Beijing, 2003 Laboratory diagnosis of SARS A systematic review of the effectiveness of antimicrobial rinse-free hand sanitizers for prevention of illness-related absenteeism in elementary school children Moderate mutation rate in the SARS coronavirus genome and its implications Using autoregressive integrated moving average (ARIMA) models to predict and monitor the number of beds occupied during a SARS outbreak in a tertiary hospital in Singapore Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV).Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS.Possible SARS coronavirus transmission during cardiopulmonary resuscitation Animal models for SARS and MERS coronaviruses Is self-sufficiency in haemotherapies a practical or necessary goal?Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex Emerging Pathogens: Challenges and Successes of Molecular Diagnostics A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection Open tracheostomy in a suspect severe acute respiratory syndrome (SARS) patient: brief technical communication Anatomy of the epidemiological literature on the 2003 SARS outbreaks in Hong Kong and Toronto: a time-stratified review When individual behaviour matters: homogeneous and network models in epidemiology Global research trends of World Health Organization's top eight emerging pathogens.Insufficient preparedness of primary care practices for pandemic influenza and the effect of a preparedness plan in Japan: a prefecture-wide cross-sectional study Public health practice vs research: implications for preparedness and disaster research review by State Health Department IRBs.Training for and maintaining public health surge capacity: a program for disease outbreak investigation by student volunteers.Coordinated response to SARS, Vancouver, Canada.Border screening for SARS.Severe acute respiratory syndrome (SARS) and healthcare workers.The impact of SARS on a tertiary care pediatric emergency department.Severe acute respiratory syndrome (SARS): the pharmacist's role.Severe acute respiratory syndrome--a new coronavirus from the Chinese dragon's lair.SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study.

P2860

Q21142648-DABC0BD2-975A-4568-BCBD-5E4912905D24 Q21144696-8DFB4267-FA83-4402-9FB3-7A0476BD98AE Q21245141-8C51C910-E9C1-4656-BD3C-7E8DB029A72C Q24198854-B16F8426-3C62-4036-B843-461822604463 Q24244611-E1710AB3-6D2B-4653-BECE-BD19CA776C9B Q24538811-1861045E-DF7C-4F6C-8B57-5442DDB82AD6 Q24556675-9120FB80-BE50-4BAD-8DCF-F3CE6769852D Q24563490-457A47B6-51B5-4C47-9C77-366BC44329EB Q24599988-4A48E9D2-48E6-42A1-9CAA-30BF95836D69 Q24675259-C6B4A925-A9B3-41BC-A40A-7431EFE6B671 Q24799664-E2EAF48B-83DD-4AE4-B76A-481586104345 Q24800258-B8A64280-3B5D-4E59-B27B-9C75014BB800 Q24811334-B1BAEFAB-3B39-40F8-BA84-981E97323295 Q24811607-93F63EA7-BB26-48A2-A674-0EECA109E12E Q24814994-990ACFB7-C7E4-4D60-84EB-11F0F2DA32EF Q25256694-9221564F-B488-41A4-9EE3-4BCD46EB65AD Q26062853-C6F219D5-0F7D-4CD4-8CE6-0B5C6DE1E8C8 Q26799857-FD3FDD3A-348F-4AB2-92F0-13210EA13EBB Q27001649-570792F2-941E-44D2-B50C-1D8139C54861 Q27011643-4E118A32-59C2-47BD-BFDB-6797696A587D Q27477706-94CB8E81-9347-42F0-AD86-BF7A9E02258B Q27485886-B0F25B08-8B9B-4D91-8E94-C21967B50CAB Q28260798-286B8121-BC43-488A-BF44-9659EC37E1CB Q28383088-575080B4-B37C-44F5-8538-DA5DB9F10D28 Q28393524-EC1BD834-245B-40D2-9E8C-4BB4F3FFD765 Q28752363-E3471B5E-91D4-4DE3-9AEA-0882CA61C959 Q28754461-8D486E7D-F4BF-4492-B408-4A8ACC0927F0 Q30151375-956CCCCB-AE26-4128-A9D1-24DB35507E24 Q30218985-4849B0BA-2647-4D8C-90F4-ABD63B2E853C Q30228537-23B98A05-856F-4154-8339-3A5500AE15D7 Q30230151-B0DDDB92-68E1-47A0-B28B-FB2A567067B3 Q30231281-0A7DDE98-ED01-4104-8067-08A297EC0874 Q30233110-C7B7CC3C-9700-46A9-B815-67A9AA610E7E Q30233111-21D41F49-4776-4386-9ABC-3EB7074D55D7 Q30233164-DFE33D9E-B6D3-44A2-B4D2-FA0D835EA92C Q30233244-6E78FAEB-1A92-44F2-9C60-49B80E9809FC Q30333365-9C4DF44A-0CE6-4736-82BF-476D08AC6F9C Q30360085-F1FFF422-08BA-427A-B1FE-2F9BE21C388B Q30369267-91B45824-06C5-4991-98C3-F8D1E6535A51 Q30372395-E5DA3B23-FB94-4352-BF56-82D85A1A1680

P2860

Identification of severe acute respiratory syndrome in Canada.

http://www.wikidata.org/entity/Q40562241

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Identification of severe acute respiratory syndrome in Canada.

@en

type

label

Identification of severe acute respiratory syndrome in Canada.

@en

altLabel

Identification of Severe Acute Respiratory Syndrome in Canada

@en

prefLabel

Identification of severe acute respiratory syndrome in Canada.

@en

P1433

Q40562241-F9179BDE-9D3C-44EF-A098-FCE20036CE77

P1476

Q40562241-2CB38FAF-134E-46B5-8769-F29FDDAD2F63

P2093

Q40562241-161CCEF9-BCAA-444D-B056-7E623D51A159

Q40562241-16653BF5-7708-47B1-B03A-A74138252F57

Q40562241-1C1AF94A-FD58-4F74-A251-4FDD16DC4B79

Q40562241-32D70339-486C-4939-AB6A-8D561DC0ABD4

Q40562241-3FE4769F-F4D3-49DC-8925-77FE6079593A

Q40562241-442977B3-C53D-44DF-8437-924121165187

Q40562241-4757682C-C32E-445B-BED5-B6EDBAB4B7D2

Q40562241-5A5D27C2-1442-4969-A320-DE0510B60457

Q40562241-6B3D748F-6DA4-43A0-B3E8-58B99B89C436

Q40562241-7F4F1980-9736-438A-B2BE-953FE0EAD04D

P304

Q40562241-19A1D3CB-B0EC-4336-8785-08305436912A

P31

Q40562241-6BEBB819-FEBC-4539-B6ED-47C2C3E85EDC

P356

Q40562241-A2869407-C0D1-428B-BB8B-7FD8186DD297

P407

Q40562241-4BA9B25C-5A1C-42F1-BE24-D72B9D3A5543

P433

Q40562241-0CF7D305-A13D-40BD-A100-90021ED02913

P478

Q40562241-FAC3B7A3-B6A2-4C8F-AEAF-D102683D49DF

P50

Q40562241-12F54045-8EF3-4016-8DFC-75D8B6E31407

Q40562241-1E4140CC-823E-41CC-BA09-3E1F0EB129AB

Q40562241-7C86D8A0-2ECC-44E8-8FA1-65F713718153

Q40562241-8FCD814C-0024-47DF-8CF8-AA35109FA6F3

Q40562241-A7CED7B2-E57F-4D44-A07B-6358F8CC1B37

Q40562241-DB59E968-C952-4B32-A948-F86F89A27319

P577

Q40562241-CAFE5CD1-0EA0-4DB2-9FD5-AB75E620BAC6

P698

Q40562241-C37A6F80-2F7B-48B7-B94E-317D17B210C7

P921

Q40562241-C4A4E78D-BE05-4C8F-B282-0E83EFBC19F9

P356

P1433

The New England Journal of Medicine

P1476

Identification of severe acute respiratory syndrome in Canada.

@en

P2093

Adrienne K Chan

http://www.w3.org/2001/XMLSchema#string

Andrew E Simor

http://www.w3.org/2001/XMLSchema#string

Canadian Severe Acute Respiratory Syndrome Study Team

http://www.w3.org/2001/XMLSchema#string

Danuta M Skowronski

http://www.w3.org/2001/XMLSchema#string

David Rose

http://www.w3.org/2001/XMLSchema#string

Dena Adachi

http://www.w3.org/2001/XMLSchema#string

Donald E Low

http://www.w3.org/2001/XMLSchema#string

Irving Salit

http://www.w3.org/2001/XMLSchema#string

Karen Green

http://www.w3.org/2001/XMLSchema#string

Martin Petric

http://www.w3.org/2001/XMLSchema#string

P304

1995-2005

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA030634

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P50

Raymond Tellier

Susan M. Poutanen

Arthur S Slutsky

P577

2003-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12671061

http://www.w3.org/2001/XMLSchema#string

P921